A brief summary of what William Gartner has been up to:
"William Gartner, whose 8-year-old company (Provista Life Sciences LLC) brought a breast cancer blood test to market in 2009 and is working on similar diagnostics for lung cancer and Alzheimer’s disease. Recently, Gartner sold Phoenix-based Provista Life Sciences LLC’s breast and lung cancer testing technologies to a new company called Provista Diagnostics Inc., which he intends to take public by the middle of next year."
Since then, William has acquired the rights to the Lung Cancer Test thru his company Global Cancer Diagnostics (GCDx), and is trying to acquire the rights to RXPC/Onko Sure to complete the effectiveness of the Lung Cancer Test.
William has licensed out the Alzheimer technology to Amarantus (AMBS) thru his other company Memory DX.
Provista has kept the Breast Cancer Testing. William is currently keeping His Promise to take Provista public thru his M & A prowess by reverse merging into RXPC. Everything will be brought together under the Provista umbrella, and from there will court licensing agreements with Big Pharma (SLR, etc).
